Your browser doesn't support javascript.
loading
Developing an Effective Glycan-Based Vaccine for Streptococcus Pyogenes.
Mahmoud, Asmaa; Toth, Istvan; Stephenson, Rachel.
Affiliation
  • Mahmoud A; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Australia.
  • Toth I; School of Chemistry and Molecular Biosciences, The University of Queensland, Woolloongabba, Australia.
  • Stephenson R; School of Pharmacy, The Universitry of Queensland, St Lucia, Australia.
Angew Chem Int Ed Engl ; 61(11): e202115342, 2022 03 07.
Article in En | MEDLINE | ID: mdl-34935243
ABSTRACT
Streptococcus pyogenes is a primary infective agent that causes approximately 700 million human infections each year, resulting in more than 500 000 deaths. Carbohydrate-based vaccines are proven to be one of the most promising subunit vaccine candidates, as the bacterial glycan pattern(s) are different from mammalian cells and show increased pathogen serotype conservancy than the protein components. In this Review we highlight reverse vaccinology for use in the development of subunit vaccines against S. pyogenes, and report reproducible methods of carbohydrate antigen production, in addition to the structure-immunogenicity correlation between group A carbohydrate epitopes and alternative vaccine antigen carrier systems. We also report recent advances used to overcome hurdles in carbohydrate-based vaccine development.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Streptococcus pyogenes / Bacterial Vaccines Language: En Journal: Angew Chem Int Ed Engl Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polysaccharides, Bacterial / Streptococcus pyogenes / Bacterial Vaccines Language: En Journal: Angew Chem Int Ed Engl Year: 2022 Document type: Article Affiliation country: Australia